These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34177810)

  • 21. Nephrogenic diabetes insipidus in a 15-year-old Hispanic female with a novel AQP2 mutation.
    Long BC; Weber ZJ; Oberlin JM; Sutter DE; Berg JM
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):1031-1034. PubMed ID: 31348762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population.
    Ghasemi S; Mojbafan M; Talebi S; Hooman N; Hoseini R
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2421. PubMed ID: 38622833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.
    Al-Thiabat H; Abu-Aqoulah A; Kanaan D; Matalka MI; Al-Sweedan S
    Am J Case Rep; 2024 May; 25():e943597. PubMed ID: 38769718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype.
    Guyon C; Lussier Y; Bissonnette P; Leduc-Nadeau A; Lonergan M; Arthus MF; Perez RB; Tiulpakov A; Lapointe JY; Bichet DG
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F489-98. PubMed ID: 19458121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus.
    Kotnik P; Battelino T; Debeljak M; Podkrajsek KT; Waldhauser F; Frøkiaer J; Nielsen S; Krzisnik C
    J Pediatr Endocrinol Metab; 2007 Apr; 20(4):483-9. PubMed ID: 17550212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
    Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
    Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mutations underlying nephrogenic diabetes insipidus in Arab families.
    Carroll P; Al-Mojalli H; Al-Abbad A; Al-Hassoun I; Al-Hamed M; Al-Amr R; Butt AI; Meyer BF
    Genet Med; 2006 Jul; 8(7):443-7. PubMed ID: 16845277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Characterization of an Aquaporin-2 Mutation Causing Nephrogenic Diabetes Insipidus.
    Li Q; Lu B; Yang J; Li C; Li Y; Chen H; Li N; Duan L; Gu F; Zhang J; Xia W
    Front Endocrinol (Lausanne); 2021; 12():665145. PubMed ID: 34512542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.
    de Mattia F; Savelkoul PJ; Kamsteeg EJ; Konings IB; van der Sluijs P; Mallmann R; Oksche A; Deen PM
    J Am Soc Nephrol; 2005 Oct; 16(10):2872-80. PubMed ID: 16120822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
    Ding C; Beetz R; Rittner G; Bartsch O
    Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
    Savelkoul PJ; De Mattia F; Li Y; Kamsteeg EJ; Konings IB; van der Sluijs P; Deen PM
    Hum Mutat; 2009 Oct; 30(10):E891-903. PubMed ID: 19585583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.
    Zang L; Gong Y; Li Y; Dou J; Lyu Z; Su X; Zhang Y; Mu Y
    Biomed Res Int; 2022; 2022():7073158. PubMed ID: 35865667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
    Sohara E; Rai T; Yang SS; Uchida K; Nitta K; Horita S; Ohno M; Harada A; Sasaki S; Uchida S
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14217-22. PubMed ID: 16968783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus.
    Ando F
    Clin Exp Nephrol; 2021 Oct; 25(10):1051-1056. PubMed ID: 34224008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Aquaporin-omics': mechanisms of aquaporin-2 loss in polyuric disorders.
    Mak A; Sung CC; Pisitkun T; Khositseth S; Knepper MA
    J Physiol; 2024 Jul; 602(13):3191-3206. PubMed ID: 37114282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.
    Moon SS; Kim HJ; Choi YK; Seo HA; Jeon JH; Lee JE; Lee JY; Kwon TH; Kim JG; Kim BW; Lee IK
    Endocr J; 2009; 56(7):905-10. PubMed ID: 19461158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compound heterozygosis with novel AQP2 gene mutation in sisters affected by autosomal congenital nephrogenic diabetes insipidus].
    Musone D; Nicosia V; Treglia A; Amoroso F; de Gemmis P; Enzo MV; Hladnik U
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
    Kamsteeg EJ; Wormhoudt TA; Rijss JP; van Os CH; Deen PM
    EMBO J; 1999 May; 18(9):2394-400. PubMed ID: 10228154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.